Nigel Westwood

The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity

Fiona Thistlethwaite, David E. Gilham, Ryan D. Guest et al. · Cancer Immunology Immunotherapy · 2017 · 395 citations · Full text

Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd–Chiari Syndrome

Raj Patel, Nicholas Lea, Michael A. Heneghan et al. · Gastroenterology · 2006 · 278 citations

Budd–chiari Syndrome, Genetic Disorder, Genetics +5

Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures

Marianna Prokopi, Giordano Pula, Ursula Mayr et al. · Blood · 2009 · 269 citations · Full text

Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value

Alexander Smith, Azim Mohamedali, Austin Kulasekararaj et al. · Blood · 2010 · 219 citations · Full text

Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma

Karin Straathof, Barry Flutter, Rebecca Wallace et al. · Science Translational Medicine · 2020 · 195 citations